2025-04-09+00:0009:31:14+00:0018000000RES-0001selec-wTEN-0001t-esubm2CON-0001LOT-0000TEN-000118000000TPA-0001LOT-0000319881CON-00012024-10-31Z2025-01-31ZMaster agreement ARBIT-2022 between VWS - Medicines Evaluation Board agency (CBG-MEB) and Netcompany Netherlands B.V. in the matter of Medicine Registration & Evaluation System (MRES)ORG-0004201865006.004.009TEN-0001TPA-0001ORG-000229ORG-0001Rijksinkoopsamenwerking (RIS)Wilhelmina van Pruisenweg 52Den Haag2595 ANNL332NLD50555596Caroline Smit00caroline.smit@rijksoverheid.nlORG-0002Netcompany Netherlands B.V.Kanaalweg 3bDelft2628 EBNL333NLD27239458+31 153030130bbe@netcompany.comhttps://www.rechtspraak.nl/Organisatie-en-contact/Organisatie/Rechtbanken/Rechtbank-Den-HaagORG-0003Arrondissementsrechtbank Den HaagPrins Clauslaan 60Den Haag2595 AJNL332NLD82946175+31 883622200voorlichting.rb.den.haag@rechtspraak.nlORG-0004Ministerie van Volksgezondheid, Welzijn en SportMedicines Evaluation Board Agency (CBG-MEB)Den Haag2511 VXNL332NLD5251117000caroline.smit@rijksoverheid.nl00234500-202571/20252025-04-10+02:002.3eforms-sdk-1.118f59ddab-6c95-4856-9b94-5903e5f42bcb9061b66d-2a6d-488e-a528-76f592170a7b2025-04-09+00:0009:10:58+00:000132014L0024can-standardNLDcgagen-pubORG-0004comp-dial201865006.004.009VWS CDP Medicine Registration & Evaluation System (MRES)The objective is to realise, implement and then operate a new Medicine Registration & Evaluation System (MRES) that supports the primary process of CBG-MEB and integrates with all relevant National and European partners. Where we speak of “System” we regard the System as an integrated solution that is composed of applications, functions, tools and (cloud) services to run and operate this system. CGD Medicine registration and evaluation system (MRES) tbv CBG (MEB).services1800000072000000487800007232000072512000The CBG-MEB’s work involves medicines available in the Netherlands and - together with our European colleagues - medicines available across Europe.anyw-eeaLOT-0000no-eu-fundspoi-exa220qualityCriterion 1 - Functionals1.1 Procedure & Task management 1.2 Planning / Workload management & Capacity Descriptive document - Medicine Registration & Evaluation System (MRES) for MEB (CBG) 1.3 Deliberative body 1.4 Knowledge & Compliance 1.5 Search & Find 1.6 Correspondence, Publishing & Reporting 1.7 Industry Portal 1.8 Reportless assessments and ePI Punten , zijn de maximaal te behalen puntenpoi-exa120qualityCriterion 2 - Non-functionals2.1 Continuity and stability 2.2 Usability 2.3 Security 2.4 Test strategy and test management Punten , zijn de maximaal te behalen puntenpoi-exa220qualityCriterion 3 – Architecture3.1 Completeness of the solution 3.2 Data integrity 3.3 Transferability and clarity of data model & data 3.4 Data migration strategy 3.5 Infrastructure: deployment and hosting 3.6 Innovation Punten , zijn de maximaal te behalen puntenpoi-exa120qualityCriterion 4 - Service management4.1 Service management Punten , zijn de maximaal te behalen puntenpoi-exa120qualityCriterion 5 - Collaboration and Contract5.1 Contract 5.2 Collaboration Punten , zijn de maximaal te behalen puntenpoi-exa200pricePrijsSee DestriptiveORG-0001ORG-0001ORG-0003ORG-0003truefalsenonenone201865006.004.009VWS CDP Medicine Registration & Evaluation System (MRES)The objective is to realise, implement and then operate a new Medicine Registration & Evaluation System (MRES) that supports the primary process of CBG-MEB and integrates with all relevant National and European partners. Where we speak of “System” we regard the System as an integrated solution that is composed of applications, functions, tools and (cloud) services to run and operate this system. CGD Medicine registration and evaluation system (MRES) tbv CBG (MEB).services1800000072000000487800007232000072512000The CBG-MEB’s work involves medicines available in the Netherlands and - together with our European colleagues - medicines available across Europe.anyw-eea2025-02-01Z2029-12-31Z2Tweemaal (2) een verlenging van 36 maanden2000-01-01Z